Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis.

PubWeight™: 1.55‹?› | Rank: Top 4%

🔗 View Article (PMID 9066361)

Published in Ann Neurol on March 01, 1997

Authors

L D Jacobs1, S E Kaba, C M Miller, R L Priore, C M Brownscheidle

Author Affiliations

1: Department of Neurology, Buffalo General Hospital, NY 14203, USA.

Articles by these authors

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol (1996) 10.39

Kinetic analysis of secretory protein traffic and characterization of golgi to plasma membrane transport intermediates in living cells. J Cell Biol (1998) 5.14

Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med (2000) 4.50

Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J (1998) 2.65

Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells. J Exp Med (1968) 2.51

CWR22: the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res (1996) 2.18

Effects of charged amino acid mutations on the bimolecular kinetics of reduction of yeast iso-1-ferricytochrome c by bovine ferrocytochrome b5. Biochemistry (1993) 2.14

Ivermectin-resistant Ostertagia circumcincta from sheep in the lower North Island and their susceptibility to other macrocyclic lactone anthelmintics. N Z Vet J (2000) 2.07

Magnetic resonance studies of intramuscular interferon beta-1a for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. Ann Neurol (1998) 1.97

Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett (1998) 1.96

Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke (1997) 1.89

Hepatocyte growth factor: a multifunctional cytokine. Lancet (1995) 1.61

N-acetylcysteine ameliorates reperfusion injury after warm hepatic ischemia. Transplantation (1995) 1.52

Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States) Cancer Causes Control (1997) 1.51

A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium. Mult Scler (1999) 1.50

Cellular differentiation of the immune system of mice. V. Class differentiation in marrow precursors of plaque-forming cells. J Exp Med (1969) 1.50

Critical graft size in adult-to-adult living donor liver transplantation: impact of the recipient's disease. Liver Transpl (2001) 1.44

Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology (1996) 1.42

Reassessing the role of medical therapy in the management of hepatic vein thrombosis. Liver Transpl Surg (1997) 1.41

Use of the superficial femoral vein as a replacement for large veins. J Vasc Surg (1991) 1.40

Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol (2000) 1.39

Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus. J Natl Cancer Inst (1971) 1.37

Central nervous system complications in liver transplant recipients--incidence, timing, and long-term follow-up. Clin Transplant (2000) 1.34

A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg (1995) 1.32

Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol (1997) 1.32

Hepatic epithelioid hemangioendothelioma: resection or transplantation, which and when? Liver Transpl Surg (1999) 1.32

Cellular differentiation of the immune system of mice. IV. Lack of class differentiation in thymic antigen-reactive cells. J Exp Med (1969) 1.31

Comparison of surgical outcomes for hepatocellular carcinoma in patients with hepatitis B versus hepatitis C: a western experience. Ann Surg Oncol (2000) 1.30

ErbB kinases and NDF signaling in human prostate cancer cells. Oncogene (1997) 1.28

Cellular differentiation of the immune system of mice. II. Frequency of unipotent splenic antigen-sensitive units after immunization with sheep erythrocytes. J Exp Med (1969) 1.26

Maternal transmission of immunity to Eimeria maxima: enzyme-linked immunosorbent assay analysis of protective antibodies induced by infection. Infect Immun (1994) 1.25

A longitudinal study of brain atrophy in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology (1999) 1.24

The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem (1979) 1.19

Safety and risk of using pediatric donor livers in adult liver transplantation. Liver Transpl (2001) 1.17

Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium. Mult Scler (2003) 1.16

Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation. Hepatology (1995) 1.16

Liver transplantation for autoimmune hepatitis. Hepatology (2000) 1.16

Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport (2000) 1.15

Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology (1997) 1.14

Information in natural languages. A new approach. JAMA (1969) 1.13

Long-term medical complications in patients surviving > or = 5 years after liver transplant. Transplantation (2000) 1.12

Prospective evaluation of the Ottawa Ankle Rules in a university sports medicine center. With a modification to increase specificity for identifying malleolar fractures. Am J Sports Med (1998) 1.12

Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg (1998) 1.11

Safe use of hepatic allografts from donors older than 70 years. Transplantation (1996) 1.09

Orthotopic liver transplantation for Wilson's disease: a single-center experience. Transplantation (2001) 1.08

Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J Am Geriatr Soc (2001) 1.06

Liver resection under total vascular isolation. Variations on a theme. Ann Surg (1993) 1.06

Eimeria maxima gametocyte antigens: potential use in a subunit maternal vaccine against coccidiosis in chickens. Vaccine (1995) 1.05

FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial. Transplantation (1995) 1.05

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation. Hepatology (1998) 1.03

A binding site for activation by the Bacillus subtilis AhrC protein, a repressor/activator of arginine metabolism. Mol Gen Genet (1995) 1.03

A statistical method for the estimation of binding parameters in a complex system. Anal Biochem (1976) 1.03

Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol (1999) 1.00

Are quantitative functional measures more sensitive to worsening MS than traditional measures? Neurology (2000) 0.99

A simple new formula to assess liver weight. Transplant Proc (2003) 0.98

Characterization of p53 in Chinese hamster cell lines CHO-K1, CHO-WBL, and CHL: implications for genotoxicity testing. Mutat Res (1999) 0.98

Use of tissue plasminogen activator in liver transplantation from donation after cardiac death donors. Am J Transplant (2010) 0.98

Adult living donor liver transplantation: the hepatologist's perspective. Hepatology (2001) 0.98

Dissecting the molecular details of prokaryotic transcriptional control by surface plasmon resonance: the methionine and arginine repressor proteins. Biosens Bioelectron (1998) 0.98

Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer (1998) 0.97

Comparison of three strains of diabetic rats with respect to the rate at which retinopathy and tactile allodynia develop. Mol Vis (2010) 0.97

Living related liver transplantation for acute liver failure in children. Liver Transpl Surg (1999) 0.97

Selective modulation of T cell memory markers CD62L and CD44 on murine draining lymph node cells following allergen and irritant treatment. Toxicol Appl Pharmacol (1997) 0.96

Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci (2001) 0.96

Prognostic factors in patients with advanced stage prostate cancer. Cancer Res (1985) 0.96

Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. J Natl Cancer Inst (1986) 0.96

Late mortality and morbidity after liver transplantation. Transplant Proc (1987) 0.95

Renal allograft survival in outbred mongrel dogs using rabbit anti-dog thymocyte serum in combination with immunosuppressive drug therapy with or without donor bone marrow. Vet Surg (1995) 0.95

Ultrastructure of the harderian gland in male albino rats. Anat Rec (1978) 0.95

Infected false aneurysms of the subclavian artery: a complication in drug addicts. J Vasc Surg (1984) 0.94

Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol (1993) 0.93

Retransplantation for late liver graft failure: predictors of mortality. Liver Transpl (2000) 0.92

Hepatic angiomyolipoma: two case reports of caudate-based lesions and review of the literature. Liver Transpl Surg (1997) 0.91

Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. J Cell Biochem Suppl (1994) 0.91

An alternative technique for in situ arterial flushing in elderly liver donors with atherosclerotic occlusive disease. Transplantation (1993) 0.91

Selective revascularization of hepatic artery thromboses after liver transplantation improves patient and graft survival. Transplantation (1997) 0.90

Retransplantation for recurrent hepatitis C. Liver Transpl Surg (1997) 0.90

A genetic analysis of melanoma--polygenic inheritance as a threshold trait. Am J Epidemiol (1981) 0.90

Liver transplantation in patients beyond age 60. Transplant Proc (1993) 0.89

A decrease in intracellular zinc level precedes the detection of early indicators of apoptosis in HL-60 cells. Apoptosis (2001) 0.89

Use of livers with microvesicular fat safely expands the donor pool. Transplantation (1997) 0.89

Liver transplantation in a patient with acute liver failure due to sickle cell intrahepatic cholestasis. Transplantation (2000) 0.89

Efficacy of tacrolimus as rescue therapy for chronic rejection in orthotopic liver transplantation: a report of the U.S. Multicenter Liver Study Group. Transplantation (1997) 0.88

Use of daclizumab as initial immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl (2001) 0.87

The Ordac method of making age adjustments in data. J Chronic Dis (1964) 0.87

Enhancing the sexual function of women living with chronic pain: a cognitive-behavioural treatment group. Pain Res Manag (2008) 0.86

Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in an Escherichia coli model of gram-negative pneumonitis in rats. Infect Immun (2000) 0.86

The relationship of the axillary nerve to arthroscopically placed capsulolabral sutures. An anatomic study. Am J Sports Med (1998) 0.85

Intrahepatic expression and release of vascular endothelial growth factor following orthotopic liver transplantation in the rat. Transplantation (2001) 0.85

Probing activation of the prokaryotic arginine transcriptional regulator using chimeric proteins. J Mol Biol (1999) 0.85

Adoptive cellular therapy of human breast and colorectal tumor targets using ex vivo activated memory T lymphocytes with potentiation by cis-diamminedichloroplatinum(II). J Surg Oncol (1994) 0.85

Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial. Urology (1988) 0.85

Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transpl Int (2000) 0.85

Brave or gullible: testing the concept that leaving susceptible parasites in refugia will slow the development of anthelmintic resistance. N Z Vet J (2008) 0.84

Cigarette smoking and periodontal disease. J Am Dent Assoc (1968) 0.84

Reduced anastomotic bleeding using new sutures with a needle-suture diameter ratio of one. Surgery (1987) 0.84

Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Leuk Res (1983) 0.83